Compare Johnson & Johnson (JNJ) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs SoundHound AI Inc — how do they compare? Johnson & Johnson trades at $261.41 (market cap $618.09B), while SoundHound AI Inc trades at $5.39 (market cap $2.45B). The key difference: Johnson & Johnson is far larger — about 252.3× SoundHound AI Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and SoundHound AI Inc for 23 Days on average.
| JNJ | SOUN | |
|---|---|---|
Market Cap | $618.09B | $2.45B |
Volume | 6,050,983 | 16,881,989 |
Sector | Health | Technology |
52-Week High | $278.43 | $21.40 |
52-Week Low | $186.00 | $5.52 |
Typical Hold Time | 129 Days | 23 Days |
Enterprise Value | $646.37B | $2.25B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
SoundHound AI (SOUN) trades at $5.39, down 4.26% on the day, with the stock showing bearish technical signals despite recent earnings beats. The company maintains strong revenue growth with 2026 projections at $203M but faces significant net losses (-$137M in 2026). Analyst sentiment remains positive with a 75% buy rating and $9.33 consensus price target, while recent news highlights expansion in automotive and restaurant voice AI deployments.
The stock presents a high-risk, high-reward opportunity with strong growth potential in voice AI markets but faces profitability challenges and negative cash flow trends. Key catalysts include continued revenue expansion and new product launches, while risks include integration challenges and persistent losses requiring careful monitoring of execution milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
